"From the first swaddle to life-saving treatment, Beaumont Children’s cares for those who matter to you most. Children and families across Southeast Michigan rely on our extensive network, advanced care and range of services."

During the past decade, Beaumont Children's Hospital-Royal Oak conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 19 clinical trials were completed, i.e. on average, 41.3% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 15 clinical trials were completed. i.e. 65.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beaumont Children's Hospital-Royal Oak" #1 sponsor was "Children's Oncology Group" with 33 trials, followed by "National Cancer Institute (NCI)" with 27 trials sponsored, "Benuvia Therapeutics Inc." with 1 trials sponsored, "Children's Healthcare of Atlanta" with 1 trials sponsored and "Martina Bebin" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beaumont Children's Hospital-Royal Oak" #1 collaborator was "National Cancer Institute (NCI)" with 33 trials as a collaborator, "Children's Oncology Group" with 2 trials as a collaborator, "American Academy of Pediatrics" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Children's Hospital Medical Center, Cincinnati" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Beaumont Children's Hospital-Royal Oak" are "Acute Lymphoblastic Leukemia" (5 trials), "B Acute Lymphoblastic Leukemia" (5 trials), "Malignant Solid Neoplasm" (5 trials), "Recurrent Osteosarcoma" (5 trials) and "Acute Myeloid Leukemia" (4 trials). Many other conditions were trialed in "Beaumont Children's Hospital-Royal Oak" in a lesser frequency.

Most popular intervention types in "Beaumont Children's Hospital-Royal Oak" are "Drug" (52 trials), "Other" (42 trials), "Procedure" (30 trials), "Radiation" (23 trials) and "Biological" (20 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (26 trials), "Vincristine Sulfate" (26 trials), "Laboratory Biomarker Analysis" (23 trials), "Doxorubicin Hydrochloride" (19 trials) and "Etoposide" (19 trials). Other intervention names were less common.

The vast majority of trials in "Beaumont Children's Hospital-Royal Oak" are 64 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Beaumont Children's Hospital-Royal Oak". undefined are not yet recruiting, 27 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Beaumont Children's Hospital-Royal Oak, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Beaumont Children's Hospital-Royal Oak, 0 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".